• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1804300-28
Device Problems Failure to Advance (2524); Device Dislodged or Dislocated (2923)
Patient Problems Angina (1710); Foreign Body In Patient (2687)
Event Date 12/22/2023
Event Type  Injury  
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.Attachment: medwatch report #0300890000-2023-8010.
 
Event Description
This event was reported thru the receipt of a medwatch which stated: describe the event or problem: per cardiac catheterization note - i attempted to cross the blockage with xience skypoint¿ stent however it would not cross.While it was being retrieved, stent came off the balloon in the proximal circumflex.There was still thrombolysis in myocardial infarction (timi) 3 flow however at this point.I focused to cross the stent struts against the vessel wall.Multiple wires, balloon and support catheters were used including pilot, fielder, run-through, whisper along with turnpike versus small support balloons but i could not cross beyond this segment.Patient was having active pain for which i decided to stabilize left main into left anterior descending artery (lad).3.5 x 30 onyx stent was then deployed from mid left main into proximal lad.Same stent balloon was used for post dilation of this stented segment.Further postdilation was done using 4.0 noncompliant balloon in left main and proximal lad.I attempted to rewire the circumflex with the stent struts, and i was able to get through the proximal stent where i had a 2.0 balloon to open up stent struts.I could still not go beyond mid circumflex where stent had dislodged.I decided to accept this result as further attempts were likely going to be unsuccessful.Impella was weaned off.Brilinta had been loaded and will be continued.Impella was removed.Preclose's were deployed and patent hemostasis was achieved.The patient tolerated the procedure well and left the cardiac catheterization laboratory pain-free and stable condition where he was taken back to an electrocardiographic a monitored site.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The reported patient effect of angina is listed in the xience skypoint everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.The investigation determined the reported difficulties and treatment appear to be related to circumstances of the procedure.Additionally, a conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18865876
MDR Text Key337217113
Report Number2024168-2024-02990
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648233265
UDI-Public(01)08717648233265(17)241009(10)2101341
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility,Company Representative
Reporter Occupation Risk Manager
Type of Report Initial,Followup
Report Date 04/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/08/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1804300-28
Device Lot Number2101341
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received03/26/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured10/10/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-